Role of non-quantal acetylcholine release in surplus polarization of mouse diaphragm fibres at the endplate zone.
1. In mouse diaphragm, with intact cholinesterase (ChE), the mean value of the resting membrane potential was significantly higher (-84.8 +/- 0.3 mV; mean +/- S.E.M.) at the endplate zone than in the extrajunctional area of the muscle fibres (-82.5 +/- 0.3 mV) at 22 degrees C. 2. This hyperpolarization of about 2-3 mV at the endplate zone was abolished within 5 min by 1 x 10(-6) M ouabain, indicating that it might be caused by an electrogenic Na(+)-K+ pump. (+)-Tubocurarine (TC; 1 x 10(-5) M) had no effect on this hyperpolarization after bath application for 10-20 min. 3. Short-term denervation (4 h), a slight increase of Mg2+ in the bath of from 1 to 4 mM and application of a Ca(2+)-free solution for 60 min also led to the disappearance of the surplus polarization. All of these factors are known to eliminate TC-induced hyperpolarization in anti-ChE-treated muscles (H-effect), which is considered to be a correlate of non-quantal acetylcholine (ACh) leakage. 4. The time courses of the decline of the H-effect and surplus polarization after denervation were identical. 5. In short-term denervated muscles with intact ChE, the surplus polarization was restored by 5 x 10(-8) M ACh, which simulates the H-effect in anti-ChE-treated muscles. The presence of 1 x 10(-6) M ouabain either prevented or abolished the effect of the bath-applied ACh.(ABSTRACT TRUNCATED AT 250 WORDS)
Nikolsky
E E
EE
Kazan Medical Institute, Tatarstan, Russia.
Zemková
H
H
Voronin
V A
VA
Vyskocil
F
F
D000109:Acetylcholine / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D002802:Cholinesterases / Q000378:metabolism; D003964:Diaphragm / Q000294:innervation / Q000378:metabolism* / Q000502:physiology; D004594:Electrophysiology; D005260:Female; D008274:Magnesium / Q000494:pharmacology; D051379:Mice; D009045:Motor Endplate / Q000378:metabolism*; D009121:Muscle Denervation; D018485:Muscle Fibers, Skeletal / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D002802:Cholinesterases; D000254:Sodium-Potassium-Exchanging ATPase; D008274:Magnesium; D000109:Acetylcholine; D002118:Calcium; D014403:Tubocurarine